# Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/mirvetuximab-soravtansine-in-fr-positive-platinum-resistant-ovarian-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kathleen N. Moore,Antoine Angelergues,Gottfried E. Konecny,Yolanda García García,Susana Banerjee,Domenica Lorusso,Jung‐Yun Lee,John W. Moroney,Nicoletta Colombo,A. Roszak,Jacqueline M. Tromp,Tashanna Myers,Jeong‐Won Lee,Mario Beiner,Casey Cosgrove,David Cibula,Lainie P. Martin,Renaud Sabatier,Joseph Buscema,Purificación Estévez-García,Lan Coffman,Shibani Nicum,Linda Duska,Sandro Pignata,Fernando Gálvez,Yuemei Wang,Michael Method,Anna Berkenblit,Diana Bello Roufai,Toon Van Gorp |
| Citations | 447 |
| DOI | 10.1056/nejmoa2309169 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://discovery.ucl.ac.uk/10184310/1/nejmoa2309169.pdf |
| OpenAlex ID | https://openalex.org/W4389376362 |
| PMID | 38055253 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Domenica Lorusso](https://scholariq.org/researchers/domenica-lorusso/)
- [Lainie P. Martin](https://scholariq.org/researchers/lainie-p-martin/)
- [Nicoletta Colombo](https://scholariq.org/researchers/nicoletta-colombo/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

## Paper topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.